natgillin/translations-raw huggingface dataset:
Because Pregabalin Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pregabalin Mylan generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pregabalin Mylan is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Ker je zdravilo Pregabalin Mylan generično zdravilo, so bile študije pri ljudeh omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Lyrica.
Because Pregabalin Mylan Pharma is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pregabalin Mylan Pharma generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pregabalin Mylan Pharma is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Ker je zdravilo Pregabalin Mylan Pharma generično zdravilo, so bile študije pri ljudeh omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Lyrica.
Because Pregabalin Sandoz GmbH is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pregabalin Sandoz GmbH generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pregabalin Sandoz is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pregabalin Sandoz generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Pregabalin Zentiva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Pregabalin Zentiva generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because prostate cancer needs testosterone and other male hormones to survive and grow, by blocking these hormones, enzalutamide slows down the growth of the prostate cancer.
Ker rak prostate potrebuje za svoj razvoj in rast hormon testosteron in druge moške hormone, enzalutamid z zaviranjem teh hormonov upočasni razširjanje raka prostate.
Because Quadramet contains small amounts of a radioactive element, samarium-153, radiations are delivered locally to the bone lesions, allowing to develop the palliative action on bone pain.
Ker Quadramet vsebuje majhne količine radioaktivnega elementa samarija-153, je sevanje lokalno na kostne lezije, kjer ima paliativni učinek – lajša kostne bolečine.
Because Raloxifene Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Raloxifene Teva generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Rasagiline Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Razagilin Mylan generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because renal elimination is the major elimination pathway, dose reduction in patients with renal impairment and dose supplementation following haemodialysis is necessary (see section 4.2 table 1).
Ker je izločanje skozi ledvice glavna eliminacijska pot, je treba pri bolnikih z okvaro ledvic odmerek zmanjšati, po hemodializi pa ustrezen odmerek dodati (glejte poglavje 4.2, preglednico 1).
Because Repaglinide Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Repaglinid Accord generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Repso is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Repso generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Ribavirin Teva Pharma B.V. is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as those of the reference medicine.
Ker je zdravilo Ribavirin Teva Pharma B.V. generično zdravilo in je biološko enakovredno referenčnemu zdravilu, se upošteva, da ima enake koristi in tveganja kot referenčno zdravilo.
Because Ribavirin Teva Pharma B.V. is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine.
Ker je zdravilo Ribavirin Teva Pharma B.V. generično zdravilo, so bile študije omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu.
Because Rivastigmine 3M Health Care Ltd is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Rivastigmin 3M Health Care Ltd generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Rivastigmine Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Rivastigmine Actavis generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because RoActemra is given in one pre-filled syringe, it is unlikely that you will receive too much.
Ker je zdravilo RoActemra pripravljeno v eni napolnjeni injekcijski brizgi, ni verjetno, da bi uporabili prevelik odmerek.
Because rotigotine enters your bloodstream through your skin, food or drink does not affect the way this medicine works.
Rotigotin vstopa v krvni obtok skozi kožo, zato hrana in pijača na delovanje zdravila ne vplivata.
Because Sabervel is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Sabervel generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Sedadex is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Sedadex generično zdravilo in je bioekvivalentno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Sepioglin is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Sepioglin generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because sevelamer binds bile acids, it may interfere with the absorption of fat soluble vitamins such as A, D, E and K.
Ker sevelamer veže žočne kisline, lahko vpliva na absorpcijo v maščobi topljivi vitaminov kot so A, D, E in K.
Because sevelamer binds bile acids, it may interfere with the absorption of fat soluble vitamins such as A, D, E and K.
Ker sevelamer veže žočne kisline, lahko vpliva na absorpcijo v maščobi topnih vitaminov kot so A, D, E in K.
Because Sevohale is a generic medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Sevohale generično zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Sildenafil Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Sildenafil Actavis generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Sildenafil Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Sildenafil Teva generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because small increases in mean serum creatinine, blood urea nitrogen (BUN), and cystatin C were observed in the controlled study of nmDMD, it is recommended that serum creatinine, BUN, and cystatin C be monitored every 6 to 12 months in nmDMD patients receiving ataluren, or more frequently as needed based on the patient’s clinical status.
Ker so v kontrolirani študiji pri bolnikih z DMD zaradi nesmiselne mutacije opazili rahlo zvišanje povprečnih koncentracij kreatinina v serumu, sečninskega dušika v krvi in cistatina C, je priporočljivo, da se pri bolnikih z DMD zaradi nesmiselne mutacije, ki prejemajo ataluren, vsakih 6 do 12 mesecev preverijo koncentracije kreatinina v serumu, sečninskega dušika v krvi in cistatina C, lahko pa tudi pogosteje, če je to potrebno glede na klinično stanje bolnika.
Because symptoms of nighttime sleep disruption and daytime sleepiness are cyclical in patients with Non-24, with severity varying according to the state of alignment of the individual patient’s circadian rhythm with the 24-hour day (least severe when fully aligned, most severe when 12 hours out of alignment), efficacy endpoints for nighttime total sleep time and daytime nap duration were based on the 25% of nights with the least nighttime sleep, and the 25% of days with the most daytime nap time.
Glede na to, da se simptomi prebujanja ponoči in zaspanosti podnevi pri bolnikih z ne-24-urnim ciklusom pojavljajo v ciklusih, pri čemer je stopnja izraženosti simptomov odvisna od stanja usklajenosti cirkadianega ritma posameznega bolnika s 24-urnim dnevom (najmanj izraženi so ob popolni usklajenosti, najbolj pa ob 12-urnem zamiku), sta opazovana dogodka za oceno učinkovitosti, skupen čas spanja ponoči in trajanje dremeža podnevi, temeljila na 25 % noči z najmanj spanca ponoči in 25 % dni z največ dremeža podnevi.
Because Tadalafil Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Tadalafil Mylan generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Telmisartan Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je Telmisartan Actavis generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Telmisartan Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Telmisartan Teva generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Telmisartan Teva Pharma is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Telmisartan Teva Pharma generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Temozolomide Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Temozolomide Accord generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Temozolomide Hexal is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Temozolomide Hexal generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Temozolomide Sandoz is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Temozolomide Sandoz generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because Temozolomide Sun is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Ker je zdravilo Temozolomide Sun generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
Because TEPADINA destroys bone marrow cells responsible for producing blood cells, regular blood tests will be taken during treatment to check your blood cell counts.
Ker zdravilo TEPADINA uničuje celice kostnega mozga, ki so odgovorne za proizvodnjo krvnih celic, bo med zdravljenjem treba opravljati redne krvne preiskave, kjer bodo preverili število krvnih celic.
Because testosterone is a male sex hormone, women who are taking Intrinsa should be monitored to see if they develop any ‘androgenic’ side effects (development of male characteristics) such as hair growth on the face, deepening of the voice or hair loss.
Ker je testosteron moški spolni hormon, je treba ženske, ki uporabljajo zdravilo Intrinsa, spremljati, da bi ugotovili, ali se pri njih pojavljajo „androgeni“ neželeni učinki (pojavljanje moških značilnosti), kot so rast dlake na obrazu, znižanje glasu ali izpadanje las.
Because testosterone is a male sex hormone, women who are taking Livensa should be monitored to see if they develop any ‘androgenic’ side effects (development of male characteristics) such as hair growth on the face, deepening of the voice or hair loss.
Ker je testosteron moški spolni hormon, je treba ženske, ki uporabljajo zdravilo Livensa, spremljati, da bi ugotovili, ali se pri njih pojavljajo „androgeni“ neželeni učinki (pojavljanje moških značilnosti), kot so rast dlake na obrazu, znižanje glasu ali izpadanje las.
Because the active substance used in HBVaxPro was already authorised for use in the EU, there have been no formal studies with HBVaxPro.
Ker je bila zdravilna učinkovina v zdravilu HBVaxPro že odobrena za uporabo v EU, uradne študije zdravila HBVaxPro niso bile izvedene.
Because the build-up of this fat in organs like the spleen, liver and bones is responsible for the symptoms of type-1 Gaucher disease, reducing its production helps prevent its build-up, and thereby helps the affected organs to function better.
Ker kopičenje te maščobe v organih, kot so vranica, jetra in kosti, povzroča simptome Gaucherjeve bolezni tipa 1, zmanjševanje njene tvorbe pomaga preprečiti kopičenje maščobe in tako izboljšati delovanje prizadetih organov.
Because the cancer needs a supply of testosterone to survive and grow, by reducing the production of testosterone, abiraterone acetate may slow the growth of the prostate cancer.
Ker rak potrebuje testosteron za preživetje in rast, lahko abirateron acetat s zmanjšanjem proizvodnje testosterona upočasni rast raka prostate.
Because the collagen lysis process following Xiapex administration is localized and does not require or result in quantifiable systemic levels of AUX-I and AUX-II, the primary pharmacodynamic activity of Xiapex cannot be evaluated in subjects and therefore, such studies have not been undertaken.
Proces razgradnje kolagena, ki sledi aplikaciji zdravila Xiapex, je lokaliziran in ne zahteva ali vodi v merljive sistemske nivoje AUX-I in AUX-II, zato primarne farmakodinamične aktivnosti zdravila Xiapex pri preskušancih ne moremo ocenjevati in torej tovrstne študije niso bile izvedene.
Because the disorder is variable in its expression, other organ system signs and symptoms not noted here may occur.
Ker se sindrom pojavlja v različnih oblikah, lahko nastopijo tudi znaki in simptomi s strani drugih organskih sistemov, ki tu niso omenjeni.
Because the extent to which DUTREBIS may be dialyzable is unknown, dosing before a dialysis session should be avoided (see section 4.2).
Ker obseg izločanja zdravila DUTREBIS pri dializi ni znan, se je treba izogibati zaužitju zdravila pred dializo (glejte poglavje 4.2).
Because the extent to which raltegravir may be dialysable is unknown, dosing before a dialysis session should be avoided.
Ker obseg izločanja raltegravija pri dializi ni znan, se je treba jemanju zdravila pred dializo izogibati.
Because the formulations are not bioequivalent, neither the chewable tablets nor the granules for oral suspension should be substituted for the 400 mg tablet (see section 5.2).
Ker farmacevtske oblike niso bioekvivalentne, se niti žvečljivih tablet niti zrnc za peroralno suspenzijo ne sme zamenjati s 400 mg tabletami (glejte poglavje 5.2).
Because the formulations are not bioequivalent, neither the granules for oral suspension nor the chewable tablets should be substituted for the 400 mg tablet (see section 5.2).
Ker farmacevtske oblike niso bioekvivalentne, se niti zrnc za peroralno suspenzijo niti žvečljivih tablet ne sme zamenjati s 400 mg tabletami (glejte poglavje 5.2).
Because the guanine analogue accumulates in T- cells and lasts longer in these cells, Atriance slows down the growth and multiplication of the cells involved in T-ALL and T-LBL.
Ker se analog gvanina kopiči v celicah T in je v njih obstojnejši, zdravilo Atriance upočasni rast in množenje celic pri limfoblastni levkemiji celic T ( T-ALL) in limfoblastnem limfomu celic T (T-LBL).
Because the hepatitis B virus can become resistant to Hepsera, the doctor should only consider prescribing Hepsera if other treatments that are less likely to lead to resistance cannot be used; decompensated liver disease (when the liver is damaged and does not function normally.
Ker lahko virus hepatitisa B postane odporen na zdravilo Hepsera, naj ga zdravnik predpiše le, če drugih zdravil, pri katerih je razvoj odpornosti manj verjeten, ni mogoče uporabiti; dekompenzirano boleznijo jeter (jetra so poškodovana in ne delujejo normalno).
Because the hepatitis B virus can become resistant to Zeffix, the doctor should only consider prescribing Zeffix if other treatments that are less likely to lead to resistance cannot be used; decompensated liver disease (when the liver does not work normally).
Ker lahko virus hepatitisa B postane odporen proti zdravilu Zeffix, naj ga zdravnik predpiše le, če drugih zdravil, pri katerih je razvoj odpornosti manj verjeten, ni mogoče uporabiti; z dekompenzirano jetrno boleznijo (jetra ne delujejo normalno).
Because the mechanism of action of pazopanib can severely affect organ growth and maturation during early post natal development in rodents (see section 5.3), pazopanib should not be given to paediatric patients younger than 2 years of age.
Mehanizem delovanja pazopaniba lahko pri glodalcih hudo prizadene rast in dozorevanje organov med zgodnjim postnatalnim obdobjem (glejte poglavje 5.3), zato se pazopaniba ne sme uporabljati pri pediatričnih bolnikih, mlajših od 2 let .
Because the number of patients that need mobilisation and collection of haematopoietic stem cells for transplantation is low, the condition is considered ‘rare’, and Mozobil was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 20 October 2004.
Ker je število bolnikov, ki potrebujejo mobilizacijo in zbiranje krvotvornih matičnih celic za presaditev, majhno, velja ta bolezen za redko, zato je bilo zdravilo Mozobil dne 20. oktobra 2004 določeno kot „zdravilo sirota” (zdravilo, ki se uporablja pri redkih boleznih).
Because the number of patients undergoing haploidentical HSCT is low, Zalmoxis was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 20 October 2003.
Ker je bolnikov, ki prejmejo haploidentični HSCT, malo, je bilo zdravilo Zalmoxis 20. oktobra 2003 določeno kot „zdravilo sirota“ (zdravilo za zdravljenje redkih bolezni).
Because the number of patients who have extravasation of anthracyclines is low, the condition is considered ‘rare’, and Savene was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 19 September 2001.
Ker je število bolnikov, pri katerih se pojavi antraciklinska ekstravazacija, majhno, in je bolezen redka, je bilo zdravilo Savene dne 19. septembra 2001 določeno kot zdravilo sirota (zdravilo, ki se uporablja pri redkih boleznih).
Because the number of patients who have long-term pain that requires painkillers to be injected directly into the spine is low, the disease is considered ‘rare’, and Prialt was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 9 July 2001.
Ker je bolnikov s kroničnimi bolečinami, ki potrebujejo protibolečinska zdravila z neposrednim vbrizgavanjem v hrbtenico, malo, velja ta bolezen za redko, zato je bilo zdravilo Prialt 9. julija 2001 določeno kot „zdravilo sirota“ (zdravilo za zdravljenje redkih bolezni).
Because the number of patients with adrenal cortical carcinoma is low, the disease is considered ‘rare’, and Lysodren was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 12 June 2002.
Ker je bolnikov s karcinomom skorje nadledvične žleze malo, velja ta bolezen za redko, zato je bilo zdravilo Lysodren dne 12. junija 2002 določeno kot „zdravilo sirota” (zdravilo za zdravljenje redkih boleznih).
Because the number of patients with adrenal insufficiency is low, the disease is considered ‘rare’, and Plenadren was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 22 May 2006.
Ker je bolnikov z adrenalno insuficienco malo, velja ta bolezen za redko, zato je bilo zdravilo Plenadren dne 22. maja 2006 določeno kot „zdravilo sirota“ (zdravilo, ki se uporablja pri redkih boleznih).
Because the number of patients with ALL is low, the disease is considered ‘rare’, and Blincyto was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 24 July 2009.
Ker je bolnikov z akutno limfoblastno levkemijo malo, velja ta bolezen za redko, zato je bilo zdravilo Blincyto 24. julija 2009 določeno kot „zdravilo sirota“ (zdravilo za zdravljenje redkih bolezni).
Because the number of patients with ALL is low, the disease is considered ‘rare’, and Evoltra was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 5 February 2002.
Ker je bolnikov z akutno limfoblastno levkemijo malo, velja ta bolezen za redko, zato je bilo zdravilo Evoltra 5. februarja 2002 določeno kot „zdravilo sirota“ (zdravilo za zdravljenje redkih bolezni).
Because the number of patients with ALL is low, the disease is considered ‘rare’, and Xaluprine was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 30 April 2009.
Ker je bolnikov z ALL malo, velja ta bolezen za redko, zato je bilo zdravilo Xaluprine dne 30. aprila 2009 določeno kot „zdravilo sirota“ (zdravilo za zdravljenje redkih bolezni).
Because the number of patients with AML is low, the disease is considered ‘rare’, and Dacogen was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 8 June 2006.
Ker je bolnikov z AML malo, velja ta bolezen za redko, zato je bilo zdravilo Dacogen 8. junija 2006 določeno kot „zdravilo sirota“ (zdravilo za zdravljenje redkih bolezni).